He was first diagnosed with chronic lymphocytic leukaemia (CLL) when he was just 36 years old ... In the wake of the news, he ...

Mike Peters of The Alarm has appealed to people to become potential stem cell donors. Peters, who was forced to cancel a US ...

At the age of 30, Nicholas Filtz was diagnosed with a rare form of cancer, and on this Veterans Day, he is sharing his cancer ...

Mike Peters, frontman of Welsh band The Alarm, has said his “future is uncertain” as he implored people to become potential ...

Mike was first diagnosed with chronic lymphocytic leukaemia (CLL) more than 29 years ago ... Mike said: "I was supposed to be preparing for a stem cell transplant now, exactly 29 years since I was ...

That was among the many special moments for 11-year-old Cooper Trueblood at the Washington Capitals’ annual Hockey Fights ...

The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...

The therapy was cleared to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (B-ALL) after showing complete remission in 63% of efficacy evaluable patients during Autolus’ ...

The FDA has approved obecabtagene autoleucel (Aucatzyl) to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Syncona's Chief Executive Officer Chris Hollowood said: "We are delighted for Autolus to receive FDA approval for its novel CAR T-cell therapy for the treatment of adult ALL. Adult ALL is a ...

The company’s lead program is ulviprubart (ABC008) and is currently in clinical trials for inclusion body myositis (IBM) and ...